SCHEMBL16848070

SCHEMBL16848070

CCCCCc1ccc(N2CCc3cc(OC)ccc3C2=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 7/20 0.46
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ HTR2A P28223 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ NPBWR1 P48145 1/20 0.42
▸ GRIN1 Q05586 1/20 0.41
▸ GRIN2B Q13224 1/20 0.41
▸ MCHR1 Q99705 1/20 0.41
▸ PDE4A P27815 1/20 0.41
▸ PDE4B Q07343 1/20 0.41
▸ PDE4C Q08493 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ S1PR1 P21453 1/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ HTR2B P41595 1/20 0.40
▸ SIGMAR1 Q99720 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16827418 0.97 AOC3 (0.47) AOC3MEN1KMT2AHTR2ANPC1
SCHEMBL16848246 0.86 AOC3 (0.48) AOC3HTR2ANPC1PKMRAB9A
SCHEMBL16827580 0.84 AOC3 (0.46) AOC3MEN1KMT2AHTR2ANPC1
SCHEMBL16848192 0.83 AOC3 (0.48) AOC3HTR2ANPC1PKMRAB9A
SCHEMBL16827555 0.82 AOC3 (0.48) AOC3HTR2ANPC1PKMRAB9A
SCHEMBL16827378 0.81 CYP24A1 (0.49) AOC3HTR2ANPC1PKMRAB9A
SCHEMBL16848194 0.81 AOC3 (0.49) AOC3NPC1PKMRAB9APDE4A
SCHEMBL16848202 0.81 AOC3 (0.61) AOC3MEN1KMT2AHTR2ANPC1
SCHEMBL29438613 0.80 PDE4A (0.55) AOC3NPC1PKMRAB9APDE4A
SCHEMBL29438611 0.80 PDE4A (0.55) AOC3NPC1PKMRAB9APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015092634-A1 1,2,3,4-TETRAHYDROISOQUINOLINE COMPOUNDS AND COMPOSITIONS AS SELECTIVE ESTROGEN RECEPTOR ANTAGONISTS AND DEGRADERS NOVARTIS AG (CH) 2015-06-25 — — WO disclosed
Send feedback